(Q40923467)

24 September 2017

1 reference

title

Beta-lactam/beta-lactamase inhibitor combinations: development, antibacterial activity and clinical applications (English)

1 reference

24 September 2017

R Sutherland

1

1 reference

24 September 2017

publication date

1 July 1995

1 reference

24 September 2017

1 reference

24 September 2017

volume

23

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

191-200

1 reference

Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Kinetic interactions of tazobactam with beta-lactamases from all major structural classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Beta-lactamase inhibitors from laboratory to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01781195

In-vitro activity of cefoperazone-sulbactam against Bacteroides species

21 January 2018

1 reference

12 December 2020

Antibacterial activity of ticarcillin in the presence of clavulanate potassium

1 reference

12 December 2020

Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors

1 reference

12 December 2020

In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients

1 reference

12 December 2020

[Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections]

1 reference

12 December 2020

In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies

1 reference

12 December 2020

6.BETA.-Halopenicillanic acids, a group of .BETA.-lactamase inhibitors

1 reference

12 December 2020

POTENTIATION OF PENICILLIN ACTION BY INHIBITION OF PENICILLINASE.

1 reference

12 December 2020

Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989

1 reference

12 December 2020

SYNERGISTIC ACTIVITY OF PENICILLINS AGAINST PENICILLINASE-PRODUCING GRAM-NEGATIVE BACILLI.

1 reference

12 December 2020

Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.

1 reference

12 December 2020

In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics

1 reference

12 December 2020

Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins

1 reference

12 December 2020

A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.

1 reference

12 December 2020

Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae

1 reference

12 December 2020

The antibacterial activity of co-amoxiclav

1 reference

12 December 2020

Timentin--ticarcillin plus clavulanic acid. A laboratory and clinical perspective. Based on an international symposium. Monte Carlo, 3-4 December 1985

1 reference

12 December 2020

Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.

1 reference

12 December 2020

A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.

1 reference

12 December 2020

Bacterial resistance to beta-lactam antibiotics: problems and solutions

1 reference

12 December 2020

Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Naturally-occurring beta-lactamase inhibitors with antibacterial activity

1 reference

12 December 2020

Penicillanic acid sulfone: interaction with RTEM .beta.-lactamase from Escherichia coli at different pH values

1 reference

12 December 2020

An enzyme from bacteria able to destroy penicillin. 1940.

1 reference

12 December 2020

Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance

1 reference

12 December 2020

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).

1 reference

12 December 2020

Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use

1 reference

12 December 2020

Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam

1 reference

12 December 2020

EXTRACTION OF A HIGHLY POTENT PENICILLIN INACTIVATOR FROM PENICILLIN RESISTANT STAPHYLOCOCCI

1 reference

12 December 2020

Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination

1 reference

12 December 2020

Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors

1 reference

12 December 2020

Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01781195

1 reference

24 September 2017

1 reference